Furthermore, SNHG16 expression is upregulated in HCC cell lines and tissues, and even more so in sorafenib-resistant HCC cells, suggesting that SNHG16 knockdown can improve sensitivity to sorafenib-resistant HCC cells in vitro and in vivo [170]. Here, SNHG16 is linked to hepatocellular carcinoma.